InvestorsHub Logo
Followers 18
Posts 1054
Boards Moderated 0
Alias Born 12/07/2002

Re: None

Monday, 08/04/2003 10:21:38 PM

Monday, August 04, 2003 10:21:38 PM

Post# of 82595
Great work by early, retro and others. This is starting to look very good indeed, there is clearly a strategy for globalization of DNAP's products and services.

Ann, you asked a question about obesity. It is very much treated as a "disease" in it own right. There was a recent paper by Mark Shriver and colleagues:

Fernandez JR, Shriver MD, Beasley TM, Rafla-Demetrious N, Parra E, Albu J, Nicklas B, Ryan AS, McKeigue PM, Hoggart CL, Weinsier RL, Allison DB. Association of African genetic admixture with resting metabolic rate and obesity among women. Obes Res. 2003 Jul;11(7):904-11.

Here is the associated press release from Penn State University:

http://www.pop.psu.edu/searchable/press/jul1003.htm

This was an important paper. It concluded that: "These results provide evidence supporting the application of admixture mapping methods to the identification of genes that result in higher levels of obesity among African-American women."

Shriver et al have previously worked on "the relationships of risk for systemic lupus erythematosus and genetic admixture and diabetes and genetic admixture."

This shows that DNAP's platform and the science behind it can identify genes associated with diesease risk and disease itself.

The paper was also picked up by a number of other news providers:

http://www.demko.com/m030710.htm

http://www.health-news.co.uk/showstory.asp?id=115106

http://www.sciencedaily.com/releases/2003/07/030711092231.htm